Literature DB >> 14576824

Inhibition of Akt kinase signalling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells.

Iwona Ciechomska1, Beata Pyrzynska, Piotr Kazmierczak, Bozena Kaminska.   

Abstract

Activation of Akt signalling pathway is frequently found in glioma cells and may contribute to their resistance to undergo apoptosis in response to conventional therapies. We found that cyclosporin A (CsA) induces apoptosis of C6 glioma cells, which is associated with transcriptional activation of fasL. In the present paper, we investigated an involvement of Akt signalling in the regulation of FasL expression in CsA-induced apoptosis. We demonstrated that the level of active Akt decreases significantly after CsA treatment, which results in the decrease of Forkhead phosphorylation and its translocation to the nucleus. It correlated with an increase of binding to the Forkhead-responsive element FHRE from the FasL promoter, as demonstrated by gel-shift assays. Although treatment with LY294002, a specific inhibitor of PI3 K, decreased the phosphorylation of Akt and increased Fkhr translocation to the nucleus, these events were not sufficient to induce FasL expression and apoptosis of C6 glioma cells. Interference with Akt/Forkhead signalling by membrane-targeted Akt or removal of the FKHR-binding sites from the FasL promoter significantly abolished its activation. These results indicate that downregulation of Akt signalling and activation of Forkhead is a prerequisite for the induction of FasL promoter. It may be clinically important for pharmacological intervention in gliomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576824     DOI: 10.1038/sj.onc.1207137

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

Review 1.  The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.

Authors:  Lars P Van Der Heide; Marco F M Hoekman; Marten P Smidt
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

2.  Apoptosis in gingival overgrowth tissues.

Authors:  A Kantarci; P Augustin; E Firatli; M C Sheff; H Hasturk; D T Graves; P C Trackman
Journal:  J Dent Res       Date:  2007-09       Impact factor: 6.116

Review 3.  Forkhead transcription factors and cardiovascular biology.

Authors:  Kyriakos N Papanicolaou; Yasuhiro Izumiya; Kenneth Walsh
Journal:  Circ Res       Date:  2008-01-04       Impact factor: 17.367

4.  Role of dephosphorylation of FOXO1 on apoptosis induced by wortmannin for non-Hodgkin's lymphoma cells.

Authors:  Zhan Qiong; Huang Ruofan; Liang Xiaohua; Zhou Xinli; Jiang Jingwei; Chu Zhaohui
Journal:  Mol Biol Rep       Date:  2009-09-11       Impact factor: 2.316

5.  Overexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis.

Authors:  Shahab Uddin; Zeenath Jehan; Maqbool Ahmed; Aisha Alyan; Fouad Al-Dayel; Azhar Hussain; Prashant Bavi; Khawla S Al-Kuraya
Journal:  Mol Med       Date:  2011-03-21       Impact factor: 6.354

6.  Calcineurin and Erk1/2-signaling pathways are involved in the antiapoptotic effect of cyclosporin A on astrocytes exposed to simulated ischemia in vitro.

Authors:  Bozena Gabryel; Anna Pudelko; Jakub Adamczyk; Ireneusz Fischer; Andrzej Malecki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-10-05       Impact factor: 3.000

7.  AKT-ing via microRNA.

Authors:  Danish Sayed; Maha Abdellatif
Journal:  Cell Cycle       Date:  2010-08-10       Impact factor: 4.534

8.  Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion.

Authors:  D S Markovic; K Vinnakota; S Chirasani; M Synowitz; H Raguet; K Stock; M Sliwa; S Lehmann; R Kälin; N van Rooijen; K Holmbeck; F L Heppner; J Kiwit; V Matyash; S Lehnardt; B Kaminska; R Glass; H Kettenmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-15       Impact factor: 11.205

9.  Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.

Authors:  Rile Li; Sibel Erdamar; Hong Dai; Thomas M Wheeler; Anna Frolov; Peter T Scardino; Timothy C Thompson; Gustavo E Ayala
Journal:  Hum Pathol       Date:  2007-06-26       Impact factor: 3.466

10.  Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.

Authors:  Y Andersson; O Engebraaten; Ø Fodstad
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.